Correlation Between Cyclo Therapeutics and THC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and THC Therapeutics, you can compare the effects of market volatilities on Cyclo Therapeutics and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and THC Therapeutics.

Diversification Opportunities for Cyclo Therapeutics and THC Therapeutics

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cyclo and THC is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and THC Therapeutics go up and down completely randomly.

Pair Corralation between Cyclo Therapeutics and THC Therapeutics

Given the investment horizon of 90 days Cyclo Therapeutics is expected to under-perform the THC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cyclo Therapeutics is 29.49 times less risky than THC Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The THC Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  0.04  in THC Therapeutics on August 28, 2024 and sell it today you would earn a total of  0.01  from holding THC Therapeutics or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cyclo Therapeutics  vs.  THC Therapeutics

 Performance 
       Timeline  
Cyclo Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
THC Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cyclo Therapeutics and THC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclo Therapeutics and THC Therapeutics

The main advantage of trading using opposite Cyclo Therapeutics and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.
The idea behind Cyclo Therapeutics and THC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments